KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
2.170
-0.260 (-10.70%)
At close: May 26, 2026, 4:00 PM EDT
2.160
-0.010 (-0.46%)
After-hours: May 26, 2026, 7:59 PM EDT
KALA BIO Market Cap
KALA BIO has a market cap or net worth of $40.34 million as of May 26, 2026. Its market cap has increased by 82.53% in one year.
Market Cap
40.34M
Enterprise Value
31.48M
1-Year Change
82.53%
Ranking
Category
Stock Price
$2.17
Market Cap Chart
Since July 20, 2017, KALA BIO's market cap has decreased from $430.50M to $40.34M, a decrease of -90.63%. That is a compound annual growth rate of -23.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 45.20M | 882.61% |
| Dec 31, 2025 | 4.60M | -85.63% |
| Dec 31, 2024 | 32.00M | 69.31% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
| Jul 20, 2017 | 430.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 50.82M |
| Estrella Immunopharma | 49.92M |
| Xilio Therapeutics | 49.36M |
| Gossamer Bio | 49.31M |
| aTyr Pharma | 48.05M |
| Plus Therapeutics | 45.22M |
| Mereo BioPharma Group | 44.42M |
| Telomir Pharmaceuticals | 44.35M |